Skip to main content

Table 1 Clinical characteristics of 376 ovarian cancer patients in TCGA database

From: Comprehensive analysis of the expression of sodium/potassium-ATPase α subunits and prognosis of ovarian serous cystadenocarcinoma

Characteristics Total
N = 376 (%)
Age
 < 60 198 (52.7)
 ≥ 60 178 (47.3)
FIGO stage
 Stage I 1 (0.3)
 Stage II 22 (5.9)
 Stage III 293 (78.6)
 Stage IV 57 (15.3)
Histologic grade
 G1 1 (0.3)
 G2 42 (11.5)
 G3 322 (88.0)
 G4 1 (0.3)
Recurrence
 No 176 (46.8)
 Yes 200 (53.2)
Tumor status
 Tumor free 71 (21.3)
 With tumor 262 (78.7)
Primary therapy outcome
 PD 27 (8.9)
 SD 22 (7.2)
 PR 43 (14.1)
 CR 213 (69.8)
Tumor residual
 NRD 66 (19.8)
 RD 267 (80.2)
Lymphatic invasion
 No 48 (32.4)
 Yes 100 (67.6)
Venous invasion
 No 40 (38.8)
 Yes 63 (61.2)
Anatomic subdivision
 Unilateral 101 (28.5)
 Bilateral 253 (71.5)
TP53 mutation
 No 26 (9.5)
 Yes 248 (90.5)
BRCA mutation
 No 249 (90.9)
 Yes 25 (9.1)
OS event
 Alived 146 (38.8)
 Dead 230 (61.2)
  1. PD progression disease, SD stable disease, PR partial response, CR complete response, NRD no residual disease, RD residual disease, OS overall survival